A critical breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate damaged p53. This crucial cancer inhibitor protein is frequently disabled in several types of malignancies, leading https://bookmarkingdepot.com/story21873568/nanobodies-reactivate-p53-the-potential-approach-for-cancer-management